153 related articles for article (PubMed ID: 26531701)
1. Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
Negrotto L; Cantó E; Río J; Tintoré M; Montalban X; Comabella M
J Neuroimmunol; 2015 Nov; 288():98-101. PubMed ID: 26531701
[TBL] [Abstract][Full Text] [Related]
2. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
[TBL] [Abstract][Full Text] [Related]
3. CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis.
Willing A; Leach OA; Ufer F; Attfield KE; Steinbach K; Kursawe N; Piedavent M; Friese MA
Eur J Immunol; 2014 Oct; 44(10):3119-28. PubMed ID: 25043505
[TBL] [Abstract][Full Text] [Related]
4. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
[TBL] [Abstract][Full Text] [Related]
5. Smoking reduces circulating CD26
Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Romme Nielsen B; Søndergaard HB; von Essen MR; Sellebjerg F
J Leukoc Biol; 2017 May; 101(5):1211-1220. PubMed ID: 28179539
[TBL] [Abstract][Full Text] [Related]
6. IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
Aristimuño C; de Andrés C; Bartolomé M; de las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
Clin Immunol; 2010 Feb; 134(2):148-57. PubMed ID: 19900844
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.
Martínez-Rodríguez JE; López-Botet M; Munteis E; Rio J; Roquer J; Montalban X; Comabella M
Clin Immunol; 2011 Dec; 141(3):348-56. PubMed ID: 21992960
[TBL] [Abstract][Full Text] [Related]
8. CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation.
Greathead L; Metcalf R; Gazzard B; Gotch F; Steel A; Kelleher P
AIDS; 2014 Jul; 28(11):1690-2. PubMed ID: 24911351
[TBL] [Abstract][Full Text] [Related]
9. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
[TBL] [Abstract][Full Text] [Related]
10. Loss of Circulating CD8+ CD161
Acquaviva M; Bassani C; Sarno N; Dalla Costa G; Romeo M; Sangalli F; Colombo B; Moiola L; Martinelli V; Comi G; Farina C
Front Immunol; 2019; 10():1922. PubMed ID: 31474991
[TBL] [Abstract][Full Text] [Related]
11. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
[TBL] [Abstract][Full Text] [Related]
12. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.
Miyazaki Y; Miyake S; Chiba A; Lantz O; Yamamura T
Int Immunol; 2011 Sep; 23(9):529-35. PubMed ID: 21712423
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
Jensen J; Langkilde AR; Frederiksen JL; Sellebjerg F
J Neuroimmunol; 2006 Oct; 179(1-2):163-72. PubMed ID: 16919783
[TBL] [Abstract][Full Text] [Related]
14. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
[TBL] [Abstract][Full Text] [Related]
16. Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
Peelen E; Thewissen M; Knippenberg S; Smolders J; Muris AH; Menheere P; Tervaert JW; Hupperts R; Damoiseaux J
J Neuroimmunol; 2013 May; 258(1-2):77-84. PubMed ID: 23517930
[TBL] [Abstract][Full Text] [Related]
17. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.
Cosgrove C; Ussher JE; Rauch A; Gärtner K; Kurioka A; Hühn MH; Adelmann K; Kang YH; Fergusson JR; Simmonds P; Goulder P; Hansen TH; Fox J; Günthard HF; Khanna N; Powrie F; Steel A; Gazzard B; Phillips RE; Frater J; Uhlig H; Klenerman P
Blood; 2013 Feb; 121(6):951-61. PubMed ID: 23255555
[TBL] [Abstract][Full Text] [Related]
18. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161
Yong YK; Saeidi A; Tan HY; Rosmawati M; Enström PF; Batran RA; Vasuki V; Chattopadhyay I; Murugesan A; Vignesh R; Kamarulzaman A; Rajarajeswaran J; Ansari AW; Vadivelu J; Ussher JE; Velu V; Larsson M; Shankar EM
Front Immunol; 2018; 9():472. PubMed ID: 29616020
[TBL] [Abstract][Full Text] [Related]
19. CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients.
Frisullo G; Nociti V; Iorio R; Plantone D; Patanella AK; Tonali PA; Batocchi AP
Hum Immunol; 2010 May; 71(5):437-41. PubMed ID: 20138197
[TBL] [Abstract][Full Text] [Related]
20. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
